November 9, 2009
The American Association of Pharmaceutical Scientists has named Russell Mumper, PhD, one of its 2009 fellows.
The honor recognizes individuals who have made sustained, remarkable scholarly and research contributions to the pharmaceutical sciences, such as original articles, scientific presentations at AAPS Annual Meetings, and patents.
Mumper is the John A. McNeill Distinguished Professor in the Division of Molecular Pharmaceutics and director of the School’s Center for Nanotechnology in Drug Delivery. His research on the creation of drug-, gene-, and vaccine-delivery systems has led to several first-in-human studies in the past twenty years. His current research focuses on nanoparticle-based systems to overcome resistance in cancer and their use as vaccine-delivery systems to co-deliver protein antigens and adjuvants. Over the past ten years, Mumper has led seven university-based product development efforts resulting in first-in-human clinical trials.